Trade Baxter International - BAX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.12 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Baxter International Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 36.46 |
Open* | 36.4 |
1-Year Change* | -30.39% |
Day's Range* | 36.06 - 36.45 |
52 wk Range | 31.01-56.92 |
Average Volume (10 days) | 4.91M |
Average Volume (3 months) | 108.57M |
Market Cap | 18.11B |
P/E Ratio | 558.34 |
Shares Outstanding | 507.32M |
Revenue | 14.82B |
EPS | 0.06 |
Dividend (Yield %) | 3.2493 |
Beta | 0.60 |
Next Earnings Date | Feb 7, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 36.08 | -0.38 | -1.04% | 36.46 | 36.56 | 35.96 |
Dec 7, 2023 | 36.46 | 0.56 | 1.56% | 35.90 | 36.53 | 35.79 |
Dec 6, 2023 | 35.87 | 0.12 | 0.34% | 35.75 | 36.07 | 35.46 |
Dec 5, 2023 | 35.75 | -0.83 | -2.27% | 36.58 | 36.58 | 35.67 |
Dec 4, 2023 | 36.84 | 0.73 | 2.02% | 36.11 | 37.12 | 36.07 |
Dec 1, 2023 | 36.49 | 0.52 | 1.45% | 35.97 | 36.61 | 35.80 |
Nov 30, 2023 | 36.02 | -0.09 | -0.25% | 36.11 | 36.35 | 35.76 |
Nov 29, 2023 | 36.35 | 0.23 | 0.64% | 36.12 | 36.77 | 36.08 |
Nov 28, 2023 | 36.30 | 0.15 | 0.41% | 36.15 | 36.50 | 36.05 |
Nov 27, 2023 | 36.37 | 0.60 | 1.68% | 35.77 | 36.44 | 35.77 |
Nov 24, 2023 | 35.97 | 0.24 | 0.67% | 35.73 | 36.19 | 35.72 |
Nov 22, 2023 | 35.80 | 0.19 | 0.53% | 35.61 | 35.93 | 35.61 |
Nov 21, 2023 | 35.64 | 0.03 | 0.08% | 35.61 | 35.77 | 35.45 |
Nov 20, 2023 | 35.57 | 0.29 | 0.82% | 35.28 | 35.82 | 34.96 |
Nov 17, 2023 | 35.39 | -0.09 | -0.25% | 35.48 | 35.65 | 35.18 |
Nov 16, 2023 | 35.38 | 0.17 | 0.48% | 35.21 | 35.49 | 34.93 |
Nov 15, 2023 | 35.26 | 0.86 | 2.50% | 34.40 | 35.27 | 34.39 |
Nov 14, 2023 | 34.28 | 0.27 | 0.79% | 34.01 | 34.67 | 33.92 |
Nov 13, 2023 | 33.65 | 0.61 | 1.85% | 33.04 | 34.07 | 32.90 |
Nov 10, 2023 | 32.73 | -0.06 | -0.18% | 32.79 | 32.86 | 32.46 |
Baxter International Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, February 7, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 Baxter International Inc Earnings Release Q4 2023 Baxter International Inc Earnings ReleaseForecast -Previous - |
Thursday, April 25, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q1 2024 Baxter International Inc Earnings Release Q1 2024 Baxter International Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 15113 | 12784 | 11673 | 11362 | 11099 |
Revenue | 15113 | 12784 | 11673 | 11362 | 11099 |
Cost of Revenue, Total | 9690 | 7626 | 7038 | 6541 | 6305 |
Gross Profit | 5423 | 5158 | 4635 | 4821 | 4794 |
Total Operating Expense | 17207 | 11129 | 10213 | 10345 | 9492 |
Selling/General/Admin. Expenses, Total | 3609 | 2619 | 2357 | 2397 | 2387 |
Research & Development | 602 | 529 | 496 | 508 | 599 |
Unusual Expense (Income) | 3306 | 355 | 322 | 899 | 210 |
Other Operating Expenses, Total | -9 | ||||
Operating Income | -2094 | 1655 | 1460 | 1017 | 1607 |
Interest Income (Expense), Net Non-Operating | -400 | -170 | -170 | -124 | -28 |
Other, Net | 141 | -8 | 2 | 77 | 38 |
Net Income Before Taxes | -2353 | 1477 | 1292 | 970 | 1617 |
Net Income After Taxes | -2421 | 1295 | 1110 | 817 | 1345 |
Net Income Before Extra. Items | -2433 | 1284 | 1102 | 807 | 1345 |
Total Extraordinary Items | 0 | 0 | 194 | 201 | |
Net Income | -2433 | 1284 | 1102 | 1001 | 1546 |
Income Available to Common Excl. Extra. Items | -2433 | 1284 | 1102 | 807 | 1345 |
Income Available to Common Incl. Extra. Items | -2433 | 1284 | 1102 | 1001 | 1546 |
Diluted Net Income | -2433 | 1284 | 1102 | 1001 | 1546 |
Diluted Weighted Average Shares | 504 | 508 | 517 | 519 | 546 |
Diluted EPS Excluding Extraordinary Items | -4.82738 | 2.52756 | 2.13153 | 1.55491 | 2.46337 |
Dividends per Share - Common Stock Primary Issue | 1.15 | 1.085 | 0.955 | 0.85 | 0.73 |
Diluted Normalized EPS | 2.10317 | 3.0315 | 2.60928 | 2.84008 | 2.4359 |
Minority Interest | -12 | -11 | -8 | -10 | 0 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 3707 | 3513 | 3887 | 3773 | 3594 |
Revenue | 3707 | 3513 | 3887 | 3773 | 3594 |
Cost of Revenue, Total | 2330 | 2206 | 2418 | 2626 | 2219 |
Gross Profit | 1377 | 1307 | 1469 | 1147 | 1375 |
Total Operating Expense | 3747 | 3384 | 3696 | 6572 | 3319 |
Selling/General/Admin. Expenses, Total | 823 | 766 | 986 | 782 | 811 |
Research & Development | 165 | 157 | 153 | 148 | 148 |
Unusual Expense (Income) | 377 | 203 | 139 | 2958 | 60 |
Operating Income | -40 | 129 | 191 | -2799 | 275 |
Interest Income (Expense), Net Non-Operating | -157 | -126 | -153 | -172 | -66 |
Other, Net | 14 | 11 | 186 | 5 | 10 |
Net Income Before Taxes | -183 | 14 | 224 | -2966 | 219 |
Net Income After Taxes | -193 | 0 | 185 | -2934 | 185 |
Minority Interest | -2 | -1 | -4 | -3 | -3 |
Net Income Before Extra. Items | -195 | -1 | 181 | -2937 | 182 |
Net Income | -141 | 44 | 181 | -2937 | 252 |
Income Available to Common Excl. Extra. Items | -195 | -1 | 181 | -2937 | 182 |
Income Available to Common Incl. Extra. Items | -141 | 44 | 181 | -2937 | 252 |
Diluted Net Income | -141 | 44 | 181 | -2937 | 252 |
Diluted Weighted Average Shares | 506 | 506 | 507 | 504 | 508 |
Diluted EPS Excluding Extraordinary Items | -0.38538 | -0.00198 | 0.357 | -5.82738 | 0.35827 |
Dividends per Share - Common Stock Primary Issue | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
Diluted Normalized EPS | 0.29051 | 0.31028 | 0.50296 | 0.43849 | 0.3937 |
Depreciation / Amortization | 52 | 52 | 58 | 81 | |
Total Extraordinary Items | 54 | 45 | 70 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 8011 | 8872 | 8411 | 7503 | 5959 |
Cash and Short Term Investments | 1718 | 2951 | 3730 | 3335 | 1838 |
Cash & Equivalents | 1718 | 2951 | 3730 | 3335 | 1838 |
Short Term Investments | |||||
Total Receivables, Net | 2752 | 2713 | 2077 | 1896 | 1840 |
Accounts Receivable - Trade, Net | 2752 | 2713 | 2077 | 1896 | 1840 |
Total Inventory | 2718 | 2453 | 1916 | 1653 | 1667 |
Prepaid Expenses | 424 | 365 | 346 | 230 | 210 |
Other Current Assets, Total | 399 | 390 | 342 | 389 | 404 |
Total Assets | 28287 | 33521 | 20019 | 18193 | 15720 |
Property/Plant/Equipment, Total - Net | 5529 | 5808 | 5325 | 5120 | 4530 |
Property/Plant/Equipment, Total - Gross | 11971 | 12358 | 11874 | 11268 | 10333 |
Accumulated Depreciation, Total | -6442 | -6550 | -6549 | -6148 | -5803 |
Goodwill, Net | 6843 | 9836 | 3217 | 3030 | 3002 |
Intangibles, Net | 6793 | 7792 | 1671 | 1471 | 1410 |
Other Long Term Assets, Total | 653 | 835 | 1038 | 762 | 599 |
Total Current Liabilities | 4745 | 4236 | 3333 | 3230 | 2814 |
Accounts Payable | 1139 | 1246 | 1043 | 892 | 998 |
Payable/Accrued | 571 | 638 | 704 | ||
Accrued Expenses | 1801 | 2087 | 1053 | 961 | 900 |
Notes Payable/Short Term Debt | 299 | 301 | 0 | 226 | 2 |
Current Port. of LT Debt/Capital Leases | 1105 | 210 | 406 | 315 | 2 |
Other Current Liabilities, Total | 401 | 392 | 260 | 198 | 208 |
Total Liabilities | 22454 | 24444 | 11330 | 10311 | 7876 |
Total Long Term Debt | 15232 | 17149 | 5786 | 4809 | 3481 |
Long Term Debt | 15170 | 17081 | 5722 | 4755 | 3481 |
Deferred Income Tax | 698 | 962 | 143 | 192 | 215 |
Minority Interest | 62 | 44 | 37 | 30 | 22 |
Other Liabilities, Total | 1717 | 2053 | 2031 | 2050 | 1344 |
Total Equity | 5833 | 9077 | 8689 | 7882 | 7844 |
Common Stock | 683 | 683 | 683 | 683 | 683 |
Additional Paid-In Capital | 6322 | 6197 | 6043 | 5955 | 5898 |
Retained Earnings (Accumulated Deficit) | 14050 | 17065 | 16328 | 15718 | 15075 |
Treasury Stock - Common | -11389 | -11488 | -11051 | -10764 | -9989 |
Other Equity, Total | -3833 | -3380 | -3314 | -3710 | -3823 |
Total Liabilities & Shareholders’ Equity | 28287 | 33521 | 20019 | 18193 | 15720 |
Total Common Shares Outstanding | 504.432 | 501.615 | 504.915 | 506.155 | 512.999 |
Note Receivable - Long Term | 211 | 224 | 222 | 231 | 176 |
Long Term Investments | 247 | 154 | 135 | 76 | 44 |
Capital Lease Obligations | 62 | 68 | 64 | 54 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 12034 | 8205 | 8099 | 8011 | 7810 |
Cash and Short Term Investments | 5788 | 1722 | 1673 | 1718 | 1601 |
Cash & Equivalents | 5788 | 1722 | 1673 | 1718 | 1601 |
Total Receivables, Net | 2553 | 2544 | 2639 | 2659 | 2555 |
Accounts Receivable - Trade, Net | 2553 | 2544 | 2639 | 2659 | 2555 |
Total Inventory | 2873 | 2897 | 2922 | 2718 | 2675 |
Prepaid Expenses | 816 | 805 | 861 | 912 | 976 |
Other Current Assets, Total | 4 | 237 | 4 | 4 | 3 |
Total Assets | 30656 | 27885 | 28291 | 28287 | 27965 |
Property/Plant/Equipment, Total - Net | 4797 | 5027 | 5554 | 5529 | 5345 |
Property/Plant/Equipment, Total - Gross | 10863 | 11028 | 11622 | 11421 | 11084 |
Accumulated Depreciation, Total | -6585 | -6534 | -6622 | -6442 | -6285 |
Goodwill, Net | 6407 | 6418 | 6868 | 6843 | 6639 |
Intangibles, Net | 6230 | 6470 | 6640 | 6793 | 6927 |
Other Long Term Assets, Total | 1034 | 1621 | 1011 | 1111 | 1244 |
Total Current Liabilities | 6209 | 5765 | 4760 | 4745 | 3708 |
Accounts Payable | 1246 | 1240 | 1290 | 1139 | 1234 |
Accrued Expenses | 2537 | 2120 | 2157 | 2202 | 2195 |
Notes Payable/Short Term Debt | 514 | 249 | 50 | 299 | 275 |
Current Port. of LT Debt/Capital Leases | 1912 | 1928 | 1103 | 1105 | 4 |
Total Liabilities | 22555 | 22316 | 22412 | 22454 | 22430 |
Total Long Term Debt | 14067 | 14306 | 15278 | 15232 | 16153 |
Long Term Debt | 14067 | 14306 | 15278 | 15232 | 16153 |
Minority Interest | 65 | 62 | 62 | 62 | 44 |
Other Liabilities, Total | 2214 | 2183 | 2312 | 2415 | 2525 |
Total Equity | 8101 | 5569 | 5879 | 5833 | 5535 |
Common Stock | 683 | 683 | 683 | 683 | 683 |
Additional Paid-In Capital | 6368 | 6341 | 6312 | 6322 | 6297 |
Retained Earnings (Accumulated Deficit) | 16015 | 13655 | 13947 | 14050 | 14015 |
Treasury Stock - Common | -11249 | -11296 | -11324 | -11389 | -11406 |
Other Equity, Total | -3716 | -3814 | -3739 | -3833 | -4054 |
Total Liabilities & Shareholders’ Equity | 30656 | 27885 | 28291 | 28287 | 27965 |
Total Common Shares Outstanding | 507.296 | 506.37 | 505.836 | 504.432 | 504.044 |
Note Receivable - Long Term | 154 | 144 | 119 | ||
Other Current Liabilities, Total | 0 | 228 | 160 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -2421 | 1295 | 1110 | 1011 | 1546 |
Cash From Operating Activities | 1211 | 2222 | 1868 | 2104 | 2017 |
Cash From Operating Activities | 1403 | 890 | 823 | 789 | 771 |
Deferred Taxes | -225 | -146 | -88 | -310 | -263 |
Non-Cash Items | 3477 | 344 | 295 | 1039 | 211 |
Cash Taxes Paid | 330 | 282 | 249 | 294 | 301 |
Cash Interest Paid | 355 | 145 | 137 | 103 | 94 |
Changes in Working Capital | -1023 | -161 | -272 | -425 | -248 |
Cash From Investing Activities | -931 | -11200 | -1179 | -1100 | -916 |
Capital Expenditures | -679 | -743 | -709 | -696 | -659 |
Other Investing Cash Flow Items, Total | -252 | -10457 | -470 | -404 | -257 |
Cash From Financing Activities | -1438 | 8245 | -345 | 498 | -2603 |
Financing Cash Flow Items | -61 | -138 | -52 | -48 | -33 |
Total Cash Dividends Paid | -573 | -530 | -473 | -423 | -376 |
Issuance (Retirement) of Stock, Net | 95 | -413 | -298 | -914 | -2194 |
Issuance (Retirement) of Debt, Net | -899 | 9326 | 478 | 1883 | 0 |
Foreign Exchange Effects | -76 | -47 | 57 | -5 | -63 |
Net Change in Cash | -1234 | -780 | 401 | 1497 | -1565 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 45 | -2421 | -2606 | 328 | 73 |
Cash From Operating Activities | 479 | 1211 | 772 | 482 | 208 |
Cash From Operating Activities | 319 | 1403 | 1069 | 735 | 380 |
Deferred Taxes | -50 | -225 | -174 | -87 | -55 |
Non-Cash Items | 35 | 3477 | 3365 | 64 | 34 |
Changes in Working Capital | 130 | -1023 | -882 | -558 | -224 |
Cash From Investing Activities | -170 | -931 | -675 | -491 | -304 |
Capital Expenditures | -172 | -679 | -479 | -311 | -140 |
Other Investing Cash Flow Items, Total | 2 | -252 | -196 | -180 | -164 |
Cash From Financing Activities | -372 | -1438 | -1319 | -1017 | -548 |
Financing Cash Flow Items | -10 | -61 | -51 | -30 | -25 |
Total Cash Dividends Paid | -146 | -573 | -427 | -281 | -140 |
Issuance (Retirement) of Stock, Net | 36 | 95 | 82 | 88 | 66 |
Issuance (Retirement) of Debt, Net | -252 | -899 | -923 | -794 | -449 |
Foreign Exchange Effects | 18 | -76 | -130 | -74 | -13 |
Net Change in Cash | -45 | -1234 | -1352 | -1100 | -657 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.9321 | 60424579 | -130104 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.6826 | 28777117 | 1166158 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2475 | 21509396 | 224988 | 2023-06-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 3.7182 | 18829047 | 746888 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.8522 | 14443482 | 5929493 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.099 | 10629326 | 1658160 | 2023-06-30 | LOW |
Macquarie Investment Management | Investment Advisor | 1.7063 | 8640616 | -583583 | 2023-06-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.6833 | 8524483 | 3677385 | 2023-06-30 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 1.6321 | 8265067 | 1060300 | 2023-06-30 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 1.499 | 7590900 | 7590900 | 2023-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.469 | 7439184 | 851057 | 2022-12-31 | LOW |
State Farm Insurance Companies | Insurance Company | 1.3533 | 6853390 | 0 | 2023-06-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 1.3502 | 6837239 | 4350617 | 2023-06-30 | LOW |
Generation Investment Management LLP | Investment Advisor/Hedge Fund | 1.301 | 6588334 | -71230 | 2023-06-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 1.1884 | 6017937 | 249550 | 2023-06-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.1788 | 5969711 | 879344 | 2023-06-30 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.1284 | 5714413 | -265373 | 2023-06-30 | HIGH |
BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 1.0412 | 5272639 | 128104 | 2023-06-30 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.9115 | 4615945 | -5287432 | 2023-06-30 | HIGH |
Fidelity Management & Research Company LLC | Investment Advisor | 0.8957 | 4535827 | -190386 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Baxter Company profile
About Baxter International Inc
Baxter International Inc. through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Baxter International Inc revenues increased 10% to $12.78B. Net income increased 17% to $1.28B. Revenues reflect Americas segment increase of 10% to $6.67B, APAC segment increase of 13% to $2.79B. Net income benefited from Americas segment income increase of 17% to $2.61B, APAC segment income increase of 5% to $623M. Dividend per share increased from $0.96 to $1.09.
Equity composition
Common Stock $1 Par, 03/11, 2B auth., 683,494,944 issd., Less 112,110,796 Shs. in Treas. @$6.1M. Insiders control approx. 0.15%. PO 6/86, 1.85M shares @$18.75 by Goldman Sachs. *FY'98-'01 are restated for disc. ops. 5/01, 2-for-1 stock split. *5/02, Co acquired Fusion Medical Technologies @ 0.1763 (2,507,881 shs. issd.).
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Df2-1W
One Baxter Pkwy
DEERFIELD
ILLINOIS 60015
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com